{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34347959",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1056/NEJMsb2104756"
    ],
    "Journal": {
      "ISSN": "1533-4406",
      "JournalIssue": {
        "Volume": "385",
        "Issue": "6",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug",
          "Day": "05"
        }
      },
      "Title": "The New England journal of medicine",
      "ISOAbbreviation": "N Engl J Med"
    },
    "ArticleTitle": "SARS-CoV-2 Variants in Patients with Immunosuppression.",
    "Pagination": {
      "StartPage": "562",
      "EndPage": "566",
      "MedlinePgn": "562-566"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-2179-2436"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Corey",
        "ForeName": "Lawrence",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Beyrer",
        "ForeName": "Chris",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Cohen",
        "ForeName": "Myron S",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Michael",
        "ForeName": "Nelson L",
        "Initials": "NL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Bedford",
        "ForeName": "Trevor",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0003-3650-8490"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "From the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle (L.C., T.B.); Johns Hopkins Bloomberg School of Public Health, Baltimore (C.B.), the Center for Infectious Disease Research (N.L.M.) and the U.S. Military HIV Research Program (M.R.), Walter Reed Army Institute of Research, Silver Spring, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill (M.S.C.)."
          }
        ],
        "LastName": "Rolland",
        "ForeName": "Morgane",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "UM1 AI068614",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068635",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "N Engl J Med",
    "NlmUniqueID": "0255562",
    "ISSNLinking": "0028-4793"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antibodies, Monoclonal"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evolution, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}